The analgesic effect of parecoxib following total abdominal hysterectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN47655040

Enrollment

Registered

2005-09-30

Start date

2002-05-15

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain Signs and Symptoms Post-operative pain

Interventions

All patients were given intraoperative: 1. Propofol 2 - 4 mg kg intravenously (i.v.) 2. Morphine 10 mg i.v. 3. Prochlorperazine 12.5 mg intramuscularly (i.m.) Patients' lungs were ventilated with ni

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients having total abdominal hysterectomy 2. American Society of Anesthesiologists (ASA) 1-11 3. Aged 20 - 65, female

Exclusion criteria

Exclusion criteria: 1. Patients having hysterectomy/morphine consumption 2. Pain 3. Sedation 4. Nausea

Design outcomes

Primary

Measure	Time frame
1. Morphine consumption 2. Pain 3. Sedation 4. Nausea	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026